Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Amland R, Selbæk G, Brækhus A, Rhodius-Meester HFM, Strand BH(2025) Sex differences in life expectancy in dementia, mild cognitive impairment (MCI), and subjective cognitive decline (SCD) Alzheimers Dement (Amst), 17(3), e70177 DOI 10.1002/dad2.70177, PubMed 40959580
Hoffart Lunding S, Kreis IV, Rødevand L, Aas M, Frogner Werner MC, Torp Johansen I, Elkjær Greenwood Ormerod MB, Reponen E, Hjell G, Ringen PA, Vik Lagerberg T, Melle I, Andreassen OA, Simonsen C, Ueland T, Steen NE(2025) Self-harming behavior linked to earlier onset of cardiovascular disease in severe mental disorders Eur Psychiatry, 1-35(in press) DOI 10.1192/j.eurpsy.2025.10106, PubMed 40947592
Ormerod MBEG, Sheikh MA, Ueland T, Hjell G, Rødevand L, Sæther LS, Lunding SH, Johansen IT, Andreou D, Ueland T, Lagerberg TV, Melle I, Djurovic S, Andreassen OA, Steen NE(2025) Minor immunomodulatory effects of psychotropics suggested in severe mental disorders: associations of antipsychotics with beta defensin 2, antidepressants with C-reactive protein, and mood stabilizers with soluble interleukin 2 receptor Eur Psychiatry, 1-28(in press) DOI 10.1192/j.eurpsy.2025.10104, PubMed 40936381